Research today. Impact tomorrow.

25% Off the entire catalogue →

Same standards. Greater possibilities.

Research Use Only18+Not for Human ConsumptionReconstitution Materials Not Supplied
Peptide Database

Longevity & cellular research

Vesilute (ED): Research Overview

Khavinson bioregulator dipeptide studied in bladder and urinary tract research.

Also known as ED · Glu-Asp

Research use onlyStrongest evidence: study type not statedReviewed
DatabaseReferences

What is Vesilute?

Vesilute is a Khavinson bioregulator dipeptide consisting of glutamic acid and aspartic acid (ED), developed at the St. Petersburg Institute of Bioregulation and Gerontology. It is specifically designed to support bladder and urinary tract function, with research indicating potential benefits for prostate health in men.

What is Vesilute researched for?

  • Research explores relief of symptoms associated with bladder dysfunction through smooth muscle regulation.
  • May support overall urinary tract function and tissue health.
  • Potential benefits for pelvic tissue health and function.
  • Research indicates potential to enhance blood flow and reduce dysfunction in prostate tissue.
  • May help alleviate symptoms associated with benign prostatic hyperplasia.
  • Part of comprehensive bioregulator protocols addressing age-related urogenital changes.
  • Supports cellular regeneration in urinary and reproductive tissues.

How does Vesilute work?

Vesilute acts on the smooth muscle cells and vascular endothelium of the urogenital system. It is proposed to: (1) regulate smooth muscle contraction and relaxation in the bladder wall, (2) enhance microcirculation and blood flow in pelvic tissues including prostate, (3) support cellular regeneration and tissue repair in the urinary tract, (4) reduce hyperemia and inflammation-related…

References

  1. Khavinson Bioregulator Peptides: Organ-Specific Effects St. Petersburg Institute of Bioregulation and Gerontology Vesilute (ED dipeptide) targets bladder and urinary tract tissues with bioregulatory effects.

  2. Vesilute (ED dipeptide) targets bladder and urinary tract tissues with bioregulatory effects.

  3. Short Peptides and Urogenital Function Russian Medical Research ED dipeptide influences smooth muscle and vascular function in urogenital tissues.

  4. ED dipeptide influences smooth muscle and vascular function in urogenital tissues.

  5. Bioregulators in Anti-Aging Medicine Khavinson VKh et al. Advances in Gerontology Organ-specific peptide bioregulators including Vesilute support tissue-specific regeneration.

  6. Organ-specific peptide bioregulators including Vesilute support tissue-specific regeneration.

Common questions

How is Vesilute different from Prostamax or other prostate-targeting peptides?

Vesilute (ED dipeptide) is a specific Khavinson bioregulator focusing on bladder and smooth muscle regulation, while Prostamax targets prostate tissue directly. They're complementary - Vesilute works on urinary tract function; Prostamax on prostate inflammation. Combining them may provide comprehensive urogenital support.

Can Vesilute improve urinary symptoms in women?

While Vesilute is studied primarily in men for prostate support, its bladder smooth muscle regulatory and microcirculation enhancement effects could theoretically benefit women with bladder dysfunction or urinary symptoms. Gender-specific research is limited, but the mechanism suggests potential for both sexes.